Eric Hines, CEO of Milestone Scientific, added, "With this strong foundation in place, we are now positioned to accelerate our momentum in both our dental and medical businesses. In addition to our revenue growth, we have taken steps to further streamline operations across the organization, aligning our efforts with our goal of achieving positive cash flow company-wide. In dental, we are capitalizing on the success of our direct sales model, our strengthened e-commerce platform, and targeted marketing campaigns to drive further adoption of our STA® system." "In medical, we are building on recent milestones — including securing Medicare Part B payment rate assignment under CPT® code 0777T in multiple jurisdictions and gaining initial coverage from commercial insurers — to advance the adoption of our CompuFlo® Epidural System in leading institutions.